Epidemiology and Clinical Course of Burkholderia cepacia Complex Infections, Particularly Those Caused by Different Burkholderia cenocepacia Strains, among Patients Attending an Italian Cystic Fibrosis Center
Open Access
- 1 April 2004
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 42 (4) , 1491-1497
- https://doi.org/10.1128/jcm.42.4.1491-1497.2004
Abstract
In this study, the epidemiology of Burkholderia cepacia complex (Bcc) recovered from the sputum of 75 patients attending the Genoa Cystic Fibrosis (CF) Center at the Gaslini Children9s Hospital (Genoa, Italy) was investigated, and the clinical course of the CF patients infected with the different species and genomovars of Bcc was evaluated. All isolates were analyzed for genomovar status by recA gene polymorphism and subsequently random amplified polymorphic DNA fingerprinting. Burkholderia cenocepacia is the predominant species recovered from the CF patients infected with Bcc at the Genoa CF Center. Of the other eight species comprising the Bcc, only a few isolates belonging to B. cepacia genomovar I, Burkholderia stabilis, and Burkholderia pyrrocinia were found. Of the four recA lineages of B. cenocepacia, most patients were infected by epidemic strains belonging to lineages IIIA and IIID, whereas only a few patients harbored IIIB strains. Patient-to-patient spread of Bcc among CF patients was mostly associated with B. cenocepacia, in particular with strains belonging to recA lineages IIIA and IIID. The mortality of CF patients infected with Bcc at the Genoa CF Center was significantly higher than mortality among CF patients not infected with Bcc. All of the deaths were associated with the presence of B. cenocepacia, except the case of a patient infected with B. cepacia genomovar I. Within B. cenocepacia, infection with epidemic strains belonging to lineages IIIA and IIID was associated with higher rates of mortality than was infection with lineage IIIB strains. No significant differences in lung function, body weight, and mortality rate were observed between patients infected with epidemic strains belonging to either B. cenocepacia IIIA or B. cenocepacia IIID.Keywords
This publication has 22 references indexed in Scilit:
- Proposal to accommodate Burkholderia cepacia genomovar VI as Burkholderia dolosa sp. nov.International Journal of Systematic and Evolutionary Microbiology, 2004
- A rhizospheric Burkholderia cepacia complex population: genotypic and phenotypic diversity of Burkholderia cenocepacia and Burkholderia ambifariaFEMS Microbiology Ecology, 2003
- Burkholderia cenocepacia sp. nov.—a new twist to an old storyResearch in Microbiology, 2003
- Burkholderia anthinasp. nov. andBurkholderia pyrrocinia, two additionalBurkholderia cepaciacomplex bacteria, may confound results of new molecular diagnostic toolsFEMS Immunology & Medical Microbiology, 2002
- Burkholderia cepacia Complex Bacteria from Clinical and Environmental Sources in Italy: Genomovar Status and Distribution of Traits Related to Virulence and TransmissibilityJournal of Clinical Microbiology, 2002
- Epidemiology ofBurkholderia cepaciaComplex in Patients with Cystic Fibrosis, CanadaEmerging Infectious Diseases, 2002
- Infection withBurkholderia cepaciaComplex Genomovars in Patients with Cystic Fibrosis: Virulent Transmissible Strains of Genomovar III Can ReplaceBurkholderia multivoransClinical Infectious Diseases, 2001
- Taxonomy and Identification of the Burkholderia cepacia ComplexJournal of Clinical Microbiology, 2001
- Burkholderia cepacia Complex Infection in Italian Patients with Cystic Fibrosis: Prevalence, Epidemiology, and Genomovar StatusJournal of Clinical Microbiology, 2001
- Phenotypic Methods for Determining Genomovar Status of the Burkholderia cepacia ComplexJournal of Clinical Microbiology, 2001